Home / Import refusals / AEK-1006551-2/11/1

FDA Import Refusal AEK-1006551-2/11/1 — ASTRAZENCA PHARMA INDIA PVT LTD

ASTRAZENCA PHARMA INDIA PVT LTD — FEI 3017190135

The FDA refused shipment AEK-1006551-2/11/1 from ASTRAZENCA PHARMA INDIA PVT LTD (India) on April 27, 2022. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charges: 118,75 This firm has 2 other import refusals on record.

Refusal Details

Date
April 27, 2022
Country
India
Product Category
Drugs and Biologics
Product Code
61PDY70 DAPAGLIFLOZIN (ANTI-DIABETIC)
Charges
118,75

Other import refusals

  • AEK-9338523-3/10003/1 (Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-8322401-2/11/1 (Wed Mar 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources